Braulke T, Geuze H J, Slot J W, Hasilik A, von Figura K
Eur J Cell Biol. 1987 Jun;43(3):316-21.
The weak bases chloroquine, primaquine, NH4Cl and the ionophore monensin exert similar but not identical effects on sorting, transport and processing of cathepsin D in several human cell lines (fibroblasts, HepG2 cells, U937, monocytes). The drugs inhibit the segregation of newly synthesized cathepsin D from the secretory route. The kinetics of transport of nonsegregated cathepsin D precursor along the secretory route is retarded resulting in a delayed hypersecretion. Higher concentrations of the drugs can arrest the intracellular transport completely. The extent of inhibition of segregation varies among the different human cell types tested. Thus, in fibroblasts the secretion can be stimulated to exceed 80%, while in U937 cells the secretion cannot be enhanced above 50% although both cell types have the same basal rate of secretion (approximately 10% of the synthesized cathepsin D). We suggest that pH-independent sorting mechanisms contribute to the targeting of cathepsin D in U937 cells. Processing of the cathepsin D remaining in cells is characteristically changed depending on the drug. The proteolytic processing is strongly inhibited by chloroquine and is rather insensitive to monensin. Unlike the other drugs, monensin blocks the formation of complex oligosaccharides in cathepsin D and allows for extensive secretion solely of molecules that are sensitive to endo H.
弱碱类药物氯喹、伯氨喹、氯化铵以及离子载体莫能菌素,对几种人类细胞系(成纤维细胞、HepG2细胞、U937细胞、单核细胞)中组织蛋白酶D的分选、转运及加工具有相似但并非完全相同的作用。这些药物抑制新合成的组织蛋白酶D从分泌途径的分离。未分离的组织蛋白酶D前体沿分泌途径的转运动力学受到阻碍,导致分泌延迟且分泌量增加。更高浓度的药物可完全阻断细胞内转运。在不同的测试人类细胞类型中,分离抑制的程度有所不同。因此,在成纤维细胞中,分泌可被刺激至超过80%,而在U937细胞中,尽管两种细胞类型的基础分泌速率相同(约占合成的组织蛋白酶D的10%),但其分泌量无法增强至50%以上。我们认为,不依赖pH的分选机制有助于组织蛋白酶D在U937细胞中的靶向定位。细胞内残留的组织蛋白酶D的加工过程会因药物不同而发生特征性变化。蛋白水解加工过程受到氯喹的强烈抑制,而对莫能菌素相对不敏感。与其他药物不同,莫能菌素会阻断组织蛋白酶D中复杂寡糖的形成,仅允许对内切糖苷酶H敏感的分子大量分泌。